KTWO (K2 Capital Acquisition Corporation Class A Ordinary Share)
Insider Trading Activity
Every open-market purchase and sale reported by KTWO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2018-09-04 | Gregory S Cole | Chief Financial Officer | MIXED | — | — |
| 2018-08-17 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | F | — | — |
| 2018-08-17 | GEORGE Z MORATIS | Global Accounting Officer | Sell | — | — |
| 2018-08-17 | Gregory S Cole | Chief Financial Officer | Sell | — | — |
| 2018-07-27 | GEORGE Z MORATIS | Global Accounting Officer | A | — | — |
| 2018-07-06 | Gregory S Cole | Chief Financial Officer | Sell | — | — |
| 2018-07-03 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | F | — | — |
| 2018-07-03 | Eric D Major | President & CEO | F | — | — |
| 2018-07-03 | Lane E Major | Chief Operating Officer | F | — | — |
| 2018-06-08 | Gregory S Cole | Chief Financial Officer | F | — | — |
| 2018-06-08 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | F | — | — |
| 2018-06-08 | Lane E Major | Chief Operating Officer | F | — | — |
| 2018-06-08 | GEORGE Z MORATIS | Global Accounting Officer | Sell | — | — |
| 2018-06-08 | Eric D Major | President & CEO | F | — | — |
| 2018-06-07 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | A | — | — |
| 2018-06-07 | Gregory S Cole | Chief Financial Officer | A | — | — |
| 2018-06-07 | DANIEL A PELAK | Director | A | — | — |
| 2018-06-07 | GEORGE Z MORATIS | Global Accounting Officer | A | — | — |
| 2018-06-07 | SEAN TRAYNOR | Director | A | — | — |
| 2018-06-07 | BRETT BRODNAX | Director | A | — | — |
| 2018-06-07 | Lane E Major | Chief Operating Officer | A | — | — |
| 2018-06-07 | Eric D Major | President & CEO | A | — | — |
| 2018-06-07 | Paul B. Queally | Director | A | — | — |
| 2018-06-07 | RAY A RANELLI | Director | A | — | — |
| 2018-06-07 | CARLOS A FERRER | Director | A | — | — |
| 2018-04-20 | RAY A RANELLI | Director | A | — | — |
| 2017-08-24 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | Sell | — | — |
| 2017-08-16 | GEORGE Z MORATIS | Global Accounting Officer | Sell | — | — |
| 2017-08-16 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | Sell | — | — |
| 2017-08-16 | Gregory S Cole | Chief Financial Officer | Sell | — | — |
| 2017-08-16 | Eric D Major | President & CEO | F | — | — |
| 2017-08-15 | Gregory S Cole | Chief Financial Officer | MIXED | — | — |
| 2017-07-05 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | F | — | — |
| 2017-07-05 | Eric D Major | President & CEO | F | — | — |
| 2017-07-05 | Gregory S Cole | Chief Financial Officer | Sell | — | — |
| 2017-06-16 | Gregory S Cole | Chief Financial Officer | MIXED | — | — |
| 2017-06-12 | CARLOS A FERRER | Director | A | — | — |
| 2017-06-08 | RAY A RANELLI | Director | A | — | — |
| 2017-06-08 | SEAN TRAYNOR | Director | A | — | — |
| 2017-06-08 | Paul B. Queally | Director | J | — | — |
| 2017-06-08 | Gregory S Cole | Chief Financial Officer | A | — | — |
| 2017-06-08 | CARLOS A FERRER | Director | A | — | — |
| 2017-06-08 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | A | — | — |
| 2017-06-08 | GEORGE Z MORATIS | Global Accounting Officer | A | — | — |
| 2017-06-08 | Paul B. Queally | Director | A | — | — |
| 2017-06-08 | DANIEL A PELAK | Director | A | — | — |
| 2017-06-08 | BRETT BRODNAX | Director | A | — | — |
| 2017-06-08 | Eric D Major | President & CEO | A | — | — |
| 2017-05-30 | JOHN PHILIP MD KOSTUIK | Chief Medical Officer | Sell | — | — |
| 2017-05-15 | GEORGE Z MORATIS | Global Accounting Officer | Sell | — | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KTWO quote page; the site-wide leaderboard is on the insider transactions hub.